About the Report
The global market for aortic stent grafts is expected to have a significant growth owing to rise in demand for minimally invasive surgeries. Increasing number of FDA approvals and clinical trials are encouraging the manufacturers and researchers to work together for development of comfortable ways of treatment. Some of the recent developments in the sector include,
In October 2020, Endologic announced first commercial implant of recently approved ALTO endograft outside US. ALTO expands the endovascular treatment of AAA patients to include short and challenging aortic necks. The ALTO endograft have ultra-low profile delivery system which is required for treating patients with challenging access and enables treating diverse set of patients. The company aims to transform the treatment of aortic disorders.
OrbusNeich and P+F announced their partnership in November 2020 for the exclusive distribution of minimally invasive heart valve products in Asia Pacific. The dry valve technology of P+F enables in series of innovation of minimally invasive heart valve products. The partnership aims to help patients in Asia Pacific region by providing transformational heart valve solutions.
Nexus Stent Graft System by Endospan Ltd. developed in December 2020 is designed to treat high risk surgical patients with ascending aorta and aortic arch diseases. The Nexus Stent Graft system is a dual module device inserted through a 20 Fr delivery system. The integrated brachiocephalic artery branch avoids the possibility of branch separation and the interlocking latch mechanism avoids the mitigation or separation of the modules.
Castor Branched Aortic Stent Graft and Delivery System developed by Shanghai MicroPort Endovascular MedTech (Group) Co. Ltd. is the world’s first stent graft system for simultaneous aorta and aortic arch repair with minimally invasive treatment. According to the team, Castor is effective in addressing the accessing difficulties. Operations using Castor are more safer and standardized than chimney, fenestration and other techniques.
An aneurysm is widening of an artery. Aorta is a large artery that delivers blood from the heart to the body organs. If an aneurysm occurs in the aorta it can expand and may rupture, resulting in death. Increasing aging population and prevalence of aortic aneurysm are the key factors expected to impel the growth of the aortic stents grafts market.
Prevalence of abdominal aortic aneurysm (AAA) rises with the age, especially after 60 years of age. Likewise, the number of AAA patients could increase with aging population. Abdominal aortic aneurysm is the common disease in Western countries; the prevalence of AAA is 2–5% in men greater than 65 years and 1–2% among women over 65 years old.
Aortic stent graft is the new treatment option for aneurysm. This treatment involves an artificial stent graft, delivered through an arterial blood vessel in the groin, fixed over the widening. This technique is called endovascular repair. There are different types of stent grafts available for aortic aneurysm.
They can differ based on deployment techniques, design, and material they are made of. Aortic stent grafts are basically used for abdominal and thoracic aortic aneurysm endovascular repair. In this report, the aortic stent grafts market is further categorized into product type and end user. The report analyses the demand for hospitals, ambulatory surgical centres and outpatient surgical centres for different regions.
Market Value and Forecast
In terms of revenue, the global aortic stent grafts market is projected to expand at 7.6% CAGR over the forecast period of 2018–2028, and is expected to be valued at US$ 4,818.5 Mn by 2028 end.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
The global demand for aortic stent grafts is growing as a result of increasing prevalence of aortic aneurysm. Increasing adoption of endovascular repair over open surgical repair and rising life expectancy rate are expected to create favourable opportunities for the players operating in the aortic stent grafts market.
Besides, favourable reimbursement policies and increasing adoption of minimally invasive surgeries among physician and patients are also propelling the growth of the aortic stent grafts market.
Increasing number of clinical trials and FDA approvals for improvement of aortic stent grafts designs has yielded new and better products to overcome anatomical constraints. Likewise, increasing partnerships and mergers among the key players for research and development and geographical expansion are some other factors expected to boost the adoption of aortic stent grafts
However, product recalls, lack of trained healthcare providers, less awareness regarding new EVAR treatment options among the general population and risk of endoleaks and other complications associated with the stent graft implants are the some of the factors expected to hamper the growth of the aortic stent grafts market.
Geographically, the global aortic stent grafts market is segmented into seven major regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific (Asia-Pacific excluding Japan), Japan and the Middle East & Africa (MEA). In terms of value, North America seized the leading share in 2017 and is expected to expand at a healthy CAGR over the forecast period of 2018–2028. Japan is expected to be the fast-growing market, in terms of revenue growth, in the global aortic stent grafts market, registering double digit growth over 2018–2028.
Examples of some of the key players are Cook Medical, Inc., W.L. Gore & Associates, MicroPort Scientific Corporation Inc., Medtronic Plc., Lombard Medical, Inc., Endologix, INC., Terumo Corporation Inc., Cardinal Health Inc., Becton, Dickinson and Company, Cryolife Inc., and Lombard Medical Inc., among others. Merger & acquisition activities are emerging as the prominent trend among the manufacturers operating in the aortic stent grafts market.
The subsequent section of the report provides analysis on the basis of regions and presents forecast in terms of value for the next 10 years. The regions covered in the report include:
- North America
- Latin America
- Rest of Latin America
- Western Europe
- Rest of Western Europe
- Eastern Europe
- Rest of Eastern Europe
- Australia & New Zealand
- Rest of APAC
- GCC Countries
- South Africa
- North Africa
- Rest of MEA
The next section analyses the sector on the basis of product type and presents forecast in terms of value (US$ Mn) for the next 10 years. The product types covered in the report include:
- Abdominal Aortic Stent Graft
- Thoracic Aortic Stent Graft
The next section analyses the sector on the basis of the end users and presents forecast in terms of value (US$ Mn) for the next 10 years. The end users covered in the report include:
- Ambulatory Surgical Centers/Outpatient Surgical Centers